Ultrasound contrast agent and gene therapy of gynecological.docVIP

 PAGE \* MERGEFORMAT 19 Ultrasound contrast agent and gene therapy of gynecological [Abstract] ultrasound contrast agent as a novel gene transfer vector for gene therapy of human diseases provides a safe and efficient new technologies. Current of ultrasound-mediated gene transfer has been involved in cardiovascular research , liver, central nervous system and other areas of research in gynecological diseases is also less, should further optimize the parameters to enhance exploration. now ultrasound contrast agent-mediated gene transfer applications in gynecological diseases are reviewed. [Keywords:] ultrasound contrast agents of gene therapy of gynecological diseases [Abstract] Ultrasound microbubble contrast agent, as a new gene transfection vector, provides a secure and efficient technique for gene therapy of human diseases.Recently, the study on ultrasound-mediated microbubble destruction delivering gene have refered to the fields including cardiovascular, hepatic, central nervous system disease and so on.The related researches on gynecologic disease are less, so it is necessary to improve parameters and make farther explorements.This review describes the application of ultrasound microbubble contrast agents in gene therapy of gynecologic disease. [Keywords:] ultrasound microbubble contrast agents, gynecologic disease, gene therapy Gene therapy is the treatment of many diseases, gynecological research focus and direction, has received wide attention at home and abroad and recognized scholars. But all along, due to lack of safe and effective targeted gene delivery system, the slow development of gene therapy of gynecological diseases. This makes it is both trying to find a security, while with higher transfection efficiency of gene therapy. In recent years, scholars found that ultrasound contrast agents can be used as a novel gene transfer vector, carrying the target gene micro-bubble contrast agent injected intravenously or in part, given cert